Dr. Blumenthal and Dr. Shamie will be responsible for providing medical and strategic clinical direction to VertiFlex, as well as assistance in its primary objective of completing its Superion Interspinous Spacer IDE pivotal trial, according to the release.
Dr. Blumenthal is a board-certified orthopedic spine surgeon with the Texas Back Institute in Plano, Texas, and clinical assistant professor of orthopedic surgery at the University of Texas Southwestern in Dallas. In his practice, he focuses on research and application of non-fusion treatments of the spine. He is also an expert in spinal arthroplasty, according to the release
Dr. Shamie is a board-certified spine surgeon and associate professor of orthopedic surgery and neurosurgery and co-director of the UCLA Comprehensive Spine Center in Los Angeles. Among his areas of clinical focus are minimally-invasive approaches to the spine, clinical trials and spinal stenosis, where he has also conducted his own clinical research on devices indicated for treatment of this condition, according to the release.
Read the VertiFlex release on Dr. Scott Blumenthal and Dr. A. Nick Shamie.
